TITLE

Easy Method of Assessing Volume of Prostate Adenocarcinoma from Estimated Tumor Area: Using Prostate Tissue Density to Bridge Gap Between Percentage Involvement and Tumor Volume

AUTHOR(S)
Torlakovic, Goran; Grover, Vaneeta K.; Torlakovic, Emina
PUB. DATE
June 2005
SOURCE
Croatian Medical Journal;2005, Vol. 46 Issue 3, p423
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Aim To determine prostate carcinoma tumor volume in routine pathology practice by using prostate tissue density. Methods Prostate tissue density was determined experimentally by using pycnometry in 57 unfixed prostate tissue fragments of different size. The percentage of prostate involvement was converted to tumor volume using the equation V = m/ρ (g/mL). Additionally, all tumor foci were outlined in 46 prostates. A high grade component was also designated. The percent of prostate involvement by the tumor and separately by the high-grade component was determined using the fine grid method (0.9 mmresolution) in all cases. Pathologist's estimated square area method was applied for comparison in 27 cases. All tumor foci were evaluated for Gleason grades. Results Prostate tissue density (ρ) was 0.98 or ≈ 1.0 (g/mL). Quicker estimated square area method was fully comparable to more laborious fine grid method for determination of percent of prostate involvement. The percentage of prostate involvement by the tumor as measured by the grid method was not significantly associated with the Gleason sum of the tumor. However, the total tumor volume that was calculated from the percent tumor involvement, mass of the prostate, and tissue density was positively associated with the Gleason sum (P = 0.035, linear-by-linear association). Conclusion Our results show that prostate tissue density can be used to determine prostate carcinoma tumor volume in routine pathology practice.
ACCESSION #
17268981

 

Related Articles

  • RESEARCH & TECHNOLOGY.  // MondayMorning;7/22/2013, Vol. 21 Issue 25, p4 

    The article reports that according to a study of older men who had died from causes other than prostate cancer, almost half were found to have prostate tumors. The study suggests that the progression of early prostate cancer is far from inevitable within a man's lifetime as many such tumors are...

  • Baseline Attitudes About Prostate Cancer Screening Moderate the Impact of Decision Aids on Screening Rates. Starosta, Amy; Luta, George; Tomko, Catherine; Schwartz, Marc; Taylor, Kathryn // Annals of Behavioral Medicine;Oct2015, Vol. 49 Issue 5, p762 

    Background: The impact of decision aids on prostate cancer screening outcomes has been inconsistent. Purpose: We assessed whether pre-existing attitudes moderated the impact of decision aids on screening. Methods: Men aged 45-70 (56.2 % Caucasian, 39.9 % African-American) were randomly assigned...

  • Prostate News Headlines April 15, 2004-- May 14, 2004.  // PharmaWatch: Cancer;June 2004, Vol. 3 Issue 6, p10 

    Lists the headlines for prostate news published in "PharmaWatch: Cancer."

  • Ursolic Acid Inhibits the Initiation, Progression of Prostate Cancer and Prolongs the Survival of TRAMP Mice by Modulating Pro-Inflammatory Pathways. Shanmugam, Muthu K.; Tina H. Ong; Kumar, Alan Prem; Chang K. Lun; Paul C. Ho; Peter T. H. Wong; Kam M. Hui; Sethi, Gautam // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Prostate cancer is one of the leading causes of cancer death among men worldwide. In this study, using transgenic adenocarcinoma of mouse prostate (TRAMP) mice, the effect of diet enriched with 1% w/w ursolic acid (UA) was investigated to evaluate the stage specific chemopreventive activity...

  • Ursolic Acid Inhibits the Initiation, Progression of Prostate Cancer and Prolongs the Survival of TRAMP Mice by Modulating Pro-Inflammatory Pathways. Shanmugam, Muthu K.; Tina H. Ong; Kumar, Alan Prem; Chang K. Lun; Paul C. Ho; Peter T. H. Wong; Kam M. Hui; Sethi, Gautam // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Prostate cancer is one of the leading causes of cancer death among men worldwide. In this study, using transgenic adenocarcinoma of mouse prostate (TRAMP) mice, the effect of diet enriched with 1% w/w ursolic acid (UA) was investigated to evaluate the stage specific chemopreventive activity...

  • Bellerophon: a hybrid method for detecting interchromo-somal rearrangements at base pair resolution using next-generation sequencing data. Hayes, Matthew; Jing Li // BMC Bioinformatics;2013, Vol. 14 Issue Suppl 5, p1 

    Background: Somatically-acquired translocations may serve as important markers for assessing the cause and nature of diseases like cancer. Algorithms to locate translocations may use next-generation sequencing (NGS) platform data. However, paired-end strategies do not accurately predict precise...

  • Doing it the Bristol way. Graham, Sarah; Humphrey, Pauline; Hilton, Sue // Synergy: Imaging & Therapy Practice;Aug2009, p22 

    The article focuses on the use of high dose rate (HDR) brachytherapy for the treatment of prostate cancer developed at Bristol Haematology and Oncology Center in Great Britain. It details the procedure for the brachytherapy stressing its involvement of a number of thin hollow catheters into the...

  • Identification of Clinically Relevant Protein Targets in Prostate Cancer with 2D-DIGE Coupled Mass Spectrometry and Systems Biology Network Platform. Ummanni, Ramesh; Mundt, Frederike; Pospisil, Heike; Venz, Simone; Scharf, Christian; Barett, Christine; Fälth, Maria; Köllermann, Jens; Walther, Reinhard; Schlomm, Thorsten; Sauter, Guido; Bokemeyer, Carsten; Sültmann, Holger; Schuppert, A.; Brümmendorf, Tim H.; Balabanov, Stefan // PLoS ONE;2011, Vol. 6 Issue 2, p1 

    Prostate cancer (PCa) is the most common type of cancer found in men and among the leading causes of cancer death in the western world. In the present study, we compared the individual protein expression patterns from histologically characterized PCa and the surrounding benign tissue obtained by...

  • Case 14.  // Journal of Endourology;Sep2008, Vol. 22 Issue 9, p2023 

    A 55-Year-Old Male Patient Has Palpable T2aNxMx Gleason 336 Prostate Cancer in the Right Lobe of the Prostate. He Is Able to Achieve Full Erections for Intercourse Without the Aid of PDE-5 Inhibitors. During a Laparoscopic Radical Prostatectomy the Left Neurovascular Bundle (NVB) Was Preserved...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics